You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • AB0197 Evaluation of Serum IL-10 and IP-10 Levels Is Useful as Prognostic Biomarkers for Selection of IL-6R Antibody (TCZ) Prior To Tumor Necrosis Factor (TNF) Inhibitor in Rheumatoid Arthritis Treatment

Citation Tools

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Rheumatoid arthritis - prognosis, predictors and outcome
AB0197 Evaluation of Serum IL-10 and IP-10 Levels Is Useful as Prognostic Biomarkers for Selection of IL-6R Antibody (TCZ) Prior To Tumor Necrosis Factor (TNF) Inhibitor in Rheumatoid Arthritis Treatment

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kameda T, Dobashi H, Inoo M, et al
AB0197 Evaluation of Serum IL-10 and IP-10 Levels Is Useful as Prognostic Biomarkers for Selection of IL-6R Antibody (TCZ) Prior To Tumor Necrosis Factor (TNF) Inhibitor in Rheumatoid Arthritis Treatment
Annals of the Rheumatic Diseases 2016;75:964-965.